Comparison of Two NN1250 Formulations in Healthy Volunteers
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in North America. The aim of this clinical trial was to investigate
if two formulations of NN1250 (insulin degludec) have the same level of drug exposure to the
body.